Adaptive Biotechnologies (ADPT) Misses Q4 EPS by 18c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $28.61 +0.21%
EPS Growth %: -266.7%
Financial Fact:
Benefit from (provision for) income taxes: 2.06M
Today's EPS Names:
VIVO, OCCI, ALZN, More
EPS Growth %: -266.7%
Financial Fact:
Benefit from (provision for) income taxes: 2.06M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.48), $0.18 worse than the analyst estimate of ($0.30). Revenue for the quarter came in at $45.78 million versus the consensus estimate of $48.45 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- DraftKings Inc. (DKNG) PT Lowered to $48 at UBS on Updated Estimates Post Q2
- Anthropic delays planned IPO from October to November - WSJ
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
